학술논문
Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis
Document Type
Article
Author
Source
In: European Stroke Journal . (European Stroke Journal, 2024)
Subject
Language
English
ISSN
23969881
23969873
23969873